Nurix Therapeutics (NRIX) Q2 2025 Earnings

8AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.76
-0.72
-0.68
-0.63

Details

Expected EPS
-0.761911
Actual EPS
-0.67
Surprise EPS
0.09
Surprise Percent
+12.06%

Description

Nurix Therapeutics (NRIX) has reported earnings of -0.67 per share for Q2 2025.

0 Comments

Share your thoughts